Abdominal aortic aneurysm From Wikipedia, the free encyclopedia Jump to: navigation, search
Abdominal aortic aneurysm Classification and external resources
CT reconstruction image of an abdominal aortic aneurysm
med/3443 emerg/27 radio/1
Abdominal aortic aneurysm (also known as AAA, pronounced "triple-a") is a localized dilatation of the abdominal aorta exceeding the normal diameter by more than 50 percent. It is caused by degeneration of the aortic wall, but the exact etiology remains unknown. Some 90 percent of abdominal aortic aneurysms occur infrarenally (below the kidneys), but they can also occur pararenally (at the level of the kidneys) or suprarenally (above the kidneys). Such aneurysms can extend to include one or both of the iliac arteries in the pelvis.
Abdominal aortic aneurysms occur most commonly in individuals between 65 and 75 years old and are more common among men and smokers. They tend to cause no symptoms, although occasionally they cause pain in the abdomen and back (due to pressure on surrounding tissues) or in the legs (due to disturbed blood flow). The major complication of abdominal aortic aneurysms is rupture, which can be life-threatening as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes. Symptomatic and large aneurysms (i.e., those greater than 5.5cm in diameter) are considered for repair by one of several surgical methods. There is moderate evidence to support screening in individuals with risk factors for abdominal aortic aneurysms.
Contents [hide] • • • • • • •
• • • • •
1 Classification 2 Signs and symptoms 3 Causes 4 Pathophysiology 5 Diagnosis 6 Screening 7 Management o 7.1 Conservative o 7.2 Medication o 7.3 Surgery 8 Prognosis 9 Epidemiology 10 History 11 Future directions 12 References
 edit] Classification Classification Abdominal aortic aneurysms are commonly divided according to their size and symptomatology. An aneurysm is usually defined as an outer aortic diameter over 3 cm (normal diameter of aorta is around 2 cm). If the outer diameter exceeds 5.5 cm, the aneurysm is considered to be large. A ruptured AAA is a clinical diagnosis involving the presence of the triad of abdominal pain, shock and a pulsatile abdominal mass. If these conditions are present, indicating AAA rupture, no further clinical investigations are needed before surgery. The post-operative mortality for an already ruptured AAA has slowly decreased over several decades but remains higher than 40%. However, if the AAA is surgically repaired before rupture, the post-operative mortality rate is substantially lower: approximately 1-6%. 
 edit] Signs and symptoms
A plate from Gray's Anatomy with yellow lines depicting the most common infrarenal location of the AAA.
The vast majority of aneurysms are asymptomatic. Possible symptoms include low back pain, flank pain, abdominal pain, groin pain or pulsating abdominal mass. The risk of rupture is high in a symptomatic aneurysm, which is therefore considered an indication for surgery. The complications include rupture, peripheral embolisation, acute aortic occlusion, and aortocaval (between the aorta and inferior vena cava) or aortoduodenal (between the aorta and the duodenum) fistulae. On physical examination, a palpable abdominal mass can be noted. Bruits can be present in case of renal or visceral arterial stenosis. The clinical manifestation of ruptured AAA usually includes excruciating pain of the lower back, flank, abdomen and groin. The bleeding usually leads to a hypovolemic shock with hypotension, tachycardia, cyanosis, and altered mental status. The mortality of AAA rupture is up to 90%. 65– 75% of patients die before they arrive at hospital and up to 90% die before they reach the operating room. The bleeding can be retroperitoneal or intraperitoneal, or the rupture can create an aortocaval or aortointestinal (between the aorta and intestine) fistula. Flank ecchymosis (appearance of a bruise) is a sign of retroperitoneal hemorrhage, and is also called Grey Turner's sign.
 edit] Causes The exact causes of the degenerative process remain unclear. There are, however, some theories and well defined risk factors. •
Cigarette smoking: Greater than 90% of people who develop a AAA have smoked at some point in their life.
Genetic influences: The influence of genetic factors is highly probable. The high familial prevalence rate is most notable in male individuals. There are many theories about the exact genetic disorder that could cause higher incidence of AAA among male members of the affected families. Some presumed that the influence of alpha 1-antitrypsin deficiency could be crucial, some experimental works favored the theory of X-linkedmutation, which would explain the lower incidence in heterozygous females. Other theories of genetic etiology have also been formulated. Connective tissue disorders have also been strongly associated with AAA. (e.g. Marfan syndrome, Ehlers-Danlos syndrome). Both relapsing polychondritis and pseudoxanthoma elasticum may cause abdominal aortic aneurysm.
Atherosclerosis: The AAA was long considered to be caused by atherosclerosis, because the walls of the AAA are frequently affected heavily. However, this theory cannot be used to explain the initial defect and the development of occlusion, which is observed in the process.
Other causes: Other causes of the development of AAA include: infection, trauma, arteritis, cystic medial necrosis (m. Erdheim).
 edit] Pathophysiology
Scheme of blood turbulences inside the Abdominal Aorta. The laminar flow is disrupted by the junction with the renal arteries.
The most striking histopathological changes of aneurysmatic aorta are seen in tunica media and intima. These include accumulation of lipids in foam cells, extracellular free cholesterol crystals, calcifications, thrombosis, and ulcerations and ruptures of the layers. There is an adventitial inflammatory infiltrate. However, the degradation of tunica media by means of proteolytic process seems to be the basic pathophysiologic mechanism of the AAA development. Some researchers report increased expression and activity of matrix metalloproteinases in individuals with AAA. This leads to elimination of elastin from the media, rendering the aortic wall more susceptible to the influence of the blood pressure. There is also a reduced amount of vasa vasorum in the abdominal aorta (compared to the thoracic aorta); consequently, the tunica media must rely mostly on diffusion for nutrition which makes it increasingly susceptible to damage. Hemodynamics affect the development of AAA. It has a predilection for the infrarenal aorta. The histological structure and mechanical characteristics of infrarenal aorta differ from those of the thoracic aorta. The diameter decreases from the root to the bifurcation, and the wall of the abdominal aorta also contains a lesser proportion of elastin. The mechanical tension in abdominal aortic wall is therefore higher than in the thoracic aortic wall. The elasticity and distensibility also decline with age, which can result in gradual dilatation of the segment. Higher intraluminal pressure in patients with arterial hypertension markedly contributes to the progression of the pathological process.
 edit] Diagnosis
Sagittal CT image of an AAA.
An abdominal aortic aneurysm is usually diagnosed by physical exam, ultrasound, or CT. Plain abdominal radiographs may show the outline of an aneurysm when its walls are calcified. This is the case in less than half of all aneurysms. Ultrasonography is used to screen for aneurysms and to determine the size. additionally free peritoneal fluid can be detected. It is noninvasive and sensitive. The presence of bowel gas or obesity may limit its usefulness. CT scan has a nearly 100% sensitivity for aneurysm and is also useful in preoperative planning, detailing the anatomy and possibility for endovascular repair. In the case of suspected rupture, it can also reliably detect retroperitoneal fluid. Alternative less often used methods for visualisation of the aneurysm include MRI and angiography.
 edit] Screening A clinical practice guideline by the U.S. Preventive Services Task Force "recommends one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in men age 65 to 75 years who have ever smoked". This is a grade B recommendation. A re-analysis of the metaanalysis estimated a number needed to screen of approximately 850 patients. The largest of the randomized controlled trials on which this guideline was based studied a screening program that consisted of: Screening men ages 65–74 years (not restricted to ever smokers). 'Men in whom abdominal aortic aneurysms (> or =3 cm in diameter) were detected were followed-up... Patients with an aortic diameter of 3·0–4·4 cm were rescanned at yearly intervals, whereas those with an aortic diameter of 4·5–5·4 cm were rescanned at 3-monthly intervals ... Surgery was considered on specific criteria (diameter > or =5.5 cm, expansion > or =1 cm per year, symptoms)'.
This trial reported significant short (number needed to screen after 4 years of approximately 590 to prevent nonfatal ruptured AAA plus AAA-related deaths) and long term (number needed to screen after 7 years of approximately 280 to prevent nonfatal ruptured AAA plus
AAA-related deaths) benefit and cost effectiveness. Subsequent randomized controlled trials also found benefit: â€˘ â€˘
number needed to screen after 4 years of 300 number needed to screen after and after 7 years of 563 (calculation).
In the U.S., effective January 1, 2007, provisions of the SAAAVE Act (Screening Abdominal Aortic Aneurysm Very Efficiently) now provide a free, one-time, ultrasound AAA screening benefit for those qualified seniors. Men who have smoked at least 100 cigarettes during their life, and men and women with a family history of AAA qualify for the one-time ultrasound screening. Enrollees must visit their healthcare professional for their Welcome to Medicare physical within six months of enrolment in order to qualify for the free screening. The Welcome to Medicare Physical Exam must be completed within the first six months of Medicare eligibility, but there is no published time limit thereafter for completion of the AAA screening. Providers who perform the physical and order the AAA screening need to document the AAA risk factors.
 edit] Management The treatment options for asymptomatic AAA are conservative management, surveillance with a view to eventual repair, and immediate repair. There are currently two modes of repair available for an AAA: open aneurysm repair (OR), and endovascular aneurysm repair (EVAR). An intervention is often recommended if the aneurysm grows more than 1 cm per year or it is bigger than 5.5 cm. Repair is also indicated for symptomatic aneurysms.
 edit] Conservative Conservative management is indicated in patients where repair carries a high risk of mortality and in patients where repair is unlikely to improve life expectancy. The two[clarification needed] mainstays of the conservative treatment are smoking cessation. Surveillance is indicated in small asymptomatic aneurysms ( less than 5.5 cm ) where the risk of repair exceeds the risk of rupture. As an AAA grows in diameter the risk of rupture increases. Surveillance until the aneurysm has reached a diameter of 5.5 cm has not been shown to have a higher risk as compared to early intervention. The threshold for repair varies slightly from individual to individual, depending on the balance of risks and benefits when considering repair versus ongoing surveillance. The size of an individual's native aorta may influence this, along with the presence of comorbitities that increase operative risk or decrease life expectancy.
 edit] Medication
No medical therapy has been found to be effective at decreasing the growth rate or rupture rate of asymtomatics AAAs. Blood pressure and lipids should however be treated like in any atherosclerotic condition. Studies have suggested possible protective effects of therapy with angiotensin converting enzyme inhibitors, beta-blockers, and statins.
 edit] Surgery Open repair
Open repair is indicated in young patients as an elective procedure, or in growing or large, symptomatic or ruptured aneurysms. It was the main surgical intervention used from the 1950s until other procedures developed. Endovascular repair
Abdominal aortic endoprosthesis, CT scan, original aneurysm marked in blue. Main article: Endovascular aneurysm repair
Endovascular repair first became practical in the 1990s and although it is now an established alternative to open repair, its role is yet to be clearly defined. It is generally indicated in older, high-risk patients or patients unfit for open repair. However, endovascular repair is feasible for only a proportion of AAAs, depending on the morphology of the aneurysm. The main advantage over open repair is that there is less peri-operative mortality, less time in intensive care, less time in hospital overall and earlier return to normal activity. Disadvantages of endovascular repair include a requirement for more frequent ongoing hospital reviews, and a higher chance of further procedures being required. According to the latest studies, the EVAR procedure does not offer any benefit for overall survival or health-related quality of life compared to open surgery, although aneurysm-related mortality is lower. In patients unfit for open repair, EVAR plus conservative management was associated with no benefit, more complications, subsequent procedures and higher costs compared to conservative management alone. Endovascular treatment for paraanastomotic aneurysms after aortobiiliac reconstruction is also a possibility.
 edit] Prognosis
Although the current standard of determining rupture risk is based on maximum diameter, it is known
AAA Size (cm) Growth rate (cm/yr) Annual rupture risk (%)
that smaller AAAs that fall below this threshold (diameter<5.5 cm) may also rupture, and larger AAAs (diameter>5.5 cm) may remain stable. In one report, it was shown that 10 - 24% of ruptured AAAs were less than 5 cm in diameter. It has also been reported that of 473 non-repaired AAAs examined from autopsy reports, there were 118 cases of rupture, 13% of which were less than 5 cm in diameter. This study also showed that 60% of the AAAs greater than 5 cm (including 54% of those AAAs between 7.1 and 10 cm) never experienced rupture. Vorp et al. later deduced from the findings of Darling et al. that if the maximum diameter criterion were followed for the 473 subjects, only 7% (34/473) of cases would have succumbed to rupture prior to surgical intervention as the diameter was less than 5 cm, with 25% (116/473) of cases possibly undergoing unnecessary surgery since these AAAs may never have ruptured. Alternative methods of rupture assessment have been recently reported. The majority of these approaches involve the numerical analysis of AAAs using the common engineering technique of the finite element method (FEM) to determine the wall stress distributions. Recent reports have shown that these stress distributions have been shown to correlate to the overall geometry of the AAA rather than solely to the maximum diameter. It is also known that wall stress alone does not completely govern failure as an AAA will usually rupture when the wall stress exceeds the wall strength. In light of this, rupture assessment may be more accurate if both the patient-specific wall stress is coupled together with patient-specific wall strength. A non-invasive method of determining patient-dependent wall strength was recently reported, with more traditional approaches to strength determination via tensile testing performed by other researchers in the field. Some of the more recently proposed AAA rupture-risk assessment methods include: AAA wall stress; AAA expansion rate; degree of asymmetry; presence of intraluminal thrombus (ILT); a rupture potential index (RPI); a finite element analysis rupture index (FEARI); biomechanical factors coupled with computer analysis; growth of ILT; geometrical parameters of the AAA; and also a method of determining AAA growth and rupture based on mathematical models.
 edit] Epidemiology
AAA is uncommon in individuals of African, Asian, and Hispanic heritage. There are 15,000 deaths yearly in the U.S. secondary to AAA rupture. The frequency varies strongly between males and females. The peak incidence is among males around 70 years of age, the prevalence among males over 60 years totals 2-6%. The frequency is much higher in smokers than in non-smokers (8:1), and the risk decreases slowly after smoking cessation. Other risk factors include hypertension and male sex. In the U.S., the incidence of AAA is 24% in the adult population.. AAA is 4-6 times more common in male siblings of known patients, with a risk of 20-30%. Rupture of the AAA occurs in 1-3% of men aged 65 or more, the mortality is 70-95%.
 edit] History The first historical records about AAA are from Ancient Rome in the 2nd century AD, when Greek surgeon Antyllus tried to treat the AAA with proximal and distal ligature, central incision and removal of thrombotic material from the aneurysm. However, attempts to treat the AAA surgically were unsuccessful until 1923. In that year, Rudolph Matas (who also proposed the concept of endoaneurysmorrhaphy), performed the first successful aortic ligation on a human. Other methods that were successful in treating the AAA included wrapping the aorta with polyethene cellophane, which induced fibrosis and restricted the growth of the aneurysm. Albert Einstein was operated on by Rudolf Nissen with use of this technique in 1949, and survived five years after the operation. Endovascular aneurysm repair was first performed in the late 1980s and has been widely adopted in the subsequent decades.
 edit] Future directions There have been many calls for alternative approaches to rupture-risk assessment over the past number of years, with many believing that a biomechanics-based approach may be more suitable than the current diameter approach. Numerical modelling is a valuable tool to researchers allowing approximate wall stresses to be calculated, thus revealing the rupture potential of a particular aneurysm. Experimental models are required to validate these numerical results, and provide a further insight into the biomechanical behaviour of the AAA. In
vivo, AAAs exhibit a varying range of material strengths from localised weak hypoxic regions to much stronger regions and areas of calcifications. Experimental models can now be manufactured using a novel technique involving the injection-moulding lost-wax manufacturing process to create patient-specific anatomically-correct AAA replicas. Work has also focused on developing more realistic material analogues to those in vivo, and recently a novel range of silicone-rubbers was created allowing the varying material properties of the AAA to be more accurately represented. These rubber models can also be used in a variety of
experimental testing from stress analysis using the photoelastic method to deterimining whether the locations of rupture experimentally correlate with those predicted numerically. With the recent advancements in AAA research, coupled with the increasing collaboration between clinicians and engineers, the future research into AAA rupture-prediction and treatment appears to be in a strong position to combat what is currently ranked as the 13th leading cause of death in the US and the 10th leading cause of death in men over the age of 55 years. A recent animal study published in the journal Nature Medicine showed that removing a single protein prevents early damage in blood vessels from triggering a later-stage, frequently lethal complication of atherosclerosis. By eliminating the gene for a signaling protein called cyclophilin A (CypA) from a strain of mice, researchers were able to provide complete protection against abdominal aortic aneurysm (AAA). New endovascular devices are being developed that are able to treat more complex and tortuous anatomies.
 edit] References 1. ^ Upchurch GR, Schaub TA (2006). "Abdominal aortic aneurysm". Am Fam Physician 73 (7): 1198–204. PMID 16623206. 2. ^ a b c Hirsch AT, Haskal ZJ, Hertzer NR, et al. (September 2006). "ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations". J Vasc Interv Radiol 17 (9): 1383–97; quiz 1398. doi:10.1097/01.RVI.0000240426.53079.46. PMID 16990459. 3. ^ a b Lindholt JS, Juul S, Fasting H, Henneberg EW (Apr 2005). "Screening for abdominal aortic aneurysms: single centre randomised controlled trial". BMJ 330 (7494): 750. doi:10.1136/bmj.38369.620162.82. PMID 15757960. 4. ^ Bown MJ, Sutton AJ, Bell PR, Sayers RD (June 2002). "A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair". The British Journal of Surgery 89 (6): 714–30. doi:10.1046/j.13652168.2002.02122.x. PMID 12027981. 5. ^ Aneurysm, Abdominal at eMedicine 6. ^ a b c d e f Abdominal Aortic Aneurysm at eMedicine 7. ^ Brown LC, Powell JT (September 1999). "Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants". Annals of Surgery 230 (3): 289–96; discussion 296–7. PMID 10493476. 8. ^ a b c d e f Treska V. et al.:Aneuryzma břišní aorty, Prague, 1999, ISBN 80-7169-724-9 9. ^ a b Greenhalgh RM, Powell JT (January 2008). "Endovascular repair of abdominal aortic aneurysm". N. Engl. J. Med. 358 (5): 494–501. doi:10.1056/NEJMct0707524. PMID 18234753. 10. ^ Clifton MA (Nov 1977). "Familial abdominal aortic aneurysms". Br J Surg. 64 (11): 765–6. doi:10.1002/bjs.1800641102. PMID 588966. 11. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 1-4160-2999-0. 12. ^ MacSweeney STR, Powell JT, Greenhalgh RM (1994). "Pathogenesis of abdominal aortic aneurysm". The British Journal of Surgery 81 (7): 935-41. doi:10.1046/j.1365-2168.2002.02122.x. 13. ^ U.S. Preventive Services Task Force (2005). "Screening for abdominal aortic aneurysm: recommendation statement". Ann. Intern. Med. 142 (3): 198–202. PMID 15684208. http://www.annals.org/cgi/content/full/142/3/198. 14. ^ Fleming C, Whitlock EP, Beil TL, Lederle FA (2005). "Screening for abdominal aortic aneurysm: a bestevidence systematic review for the U.S. Preventive Services Task Force". Ann. Intern. Med. 142 (3): 203– 11. PMID 15684209. http://www.annals.org/cgi/content/full/142/3/203.ACP Journal Club 15. ^ Recommendation ratings
16. ^ Cinà CS, Devereaux PJ (2005). "Review: population-based screening for abdominal aortic aneurysm reduces cause-specific mortality in older men". ACP J. Club 143 (1): 11. PMID 15989299. http://www.acpjc.org/Content/143/1/issue/ACPJC-2005-143-1-011.htm. 17. ^ a b Ashton HA, Buxton MJ, Day NE, et al. (2002). "The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial". Lancet 360 (9345): 1531–9. doi:10.1016/S0140-6736(02)11522-4. PMID 12443589. ACP Journal Club 18. ^ Cina CS (2003). "Screening for abdominal aortic aneurysm reduced death from AAA in older men". ACP J. Club 138 (3): 66. PMID 12725621. 19. ^ Kim LG, P Scott RA, Ashton HA, Thompson SG (2007). "A sustained mortality benefit from screening for abdominal aortic aneurysm". Ann. Intern. Med. 146 (10): 699–706. PMID 17502630. 20. ^ Multicentre Aneurysm Screening Study Group (2002). "Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomized controlled trial". BMJ 325 (7373): 1135. doi:10.1136/bmj.325.7373.1135. PMID 12433761.ACP Journal Club 21. ^ Lindholt JS, Juul S, Fasting H, Henneberg EW (2005). "Screening for abdominal aortic aneurysms: single centre randomised controlled trial". BMJ 330 (7494): 750. doi:10.1136/bmj.38369.620162.82. PMID 15757960. ACP Journal Club 22. ^ Ashton HA, Gao L, Kim LG, Druce PS, Thompson SG, Scott RA (2007). "Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms". The British journal of surgery 94 (6): 696–701. doi:10.1002/bjs.5780. PMID 17514666. 23. ^ a b c Ballard DJ, Filardo G, Fowkes G, Powell JT (2008). "Surgery for small asymptomatic abdominal aortic aneurysms". Cochrane Database Syst Rev (4): CD001835. doi:10.1002/14651858.CD001835.pub2. PMID 18843626. 24. ^ Powell JT, Brown LC, Forbes JF, et al. (Jun 2007). "Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial". Br J Surg 94 (6): 702–8. doi:10.1002/bjs.5778. PMID 17514693. 25. ^ Lederle FA, Wilson SE, Johnson GR, et al. (May 2002). "Immediate repair compared with surveillance of small abdominal aortic aneurysms". N Engl J Med 346 (19): 1437–44. doi:10.1056/NEJMoa012573. PMID 12000813. http://content.nejm.org/cgi/content/full/346/19/1437. 26. ^ Hackam DG, Thiruchelvam D, Redelmeier DA (Aug 2006). "Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study". Lancet 368 (9536): 659–65. doi:10.1016/S01406736(06)69250-7. PMID 16920471. 27. ^ Powell JT, Brown LC, Greenhalgh RM, Thompson SG (Jan 2008). "The rupture rate of large abdominal aortic aneurysms: is this modified by anatomical suitability for endovascular repair?". Ann Surg 247 (1): 173–9. doi:10.1097/SLA.0b013e3181557d2a. PMID 18156938. 28. ^ Rutherford RB (Jun 2006). "Randomized EVAR trials and advent of level i evidence: a paradigm shift in management of large abdominal aortic aneurysms?". Semin Vasc Surg 19 (2): 69–74. doi:10.1053/j.semvascsurg.2006.03.001. PMID 16782510. 29. ^ Lederle FA, Kane RL, MacDonald R, Wilt TJ (2007). "Systematic review: repair of unruptured abdominal aortic aneurysm". Ann. Intern. Med. 146 (10): 735–41. PMID 17502634. 30. ^ "Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial". Lancet 365 (9478): 2179–86. 2005. doi:10.1016/S01406736(05)66627-5. PMID 15978925. 31. ^ Blankensteijn JD, de Jong SE, Prinssen M, et al. (Jun 2005). "Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms". N Engl J Med 352 (23): 2398–405. doi:10.1056/NEJMoa051255. PMID 15944424. http://content.nejm.org/cgi/content/full/352/23/2398. 32. ^ "Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial". Lancet 365 (9478): 2187–92. 2005. doi:10.1016/S0140-6736(05)66628-7. PMID 15978926. 33. ^ Amato ACA, Kahlberg AK, Bertoglio LB, Melissano GM, Chiesa RC (2008). "[http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492008000300016&lng=en Endovascular treatment of a triple paraanastomotic aneurysm after aortobiiliac reconstruction]". J Vasc Bras 7 (3): 1-3. doi:10.1590/S1677-54492008000300016. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-54492008000300016&lng=en. 34. ^ Bernstein EF, Chan EL (September 1984). "Abdominal aortic aneurysm in high-risk patients. Outcome of selective management based on size and expansion rate". Ann. Surg. 200 (3): 255–63. PMID 6465980. 35. ^ Brewster DC, Cronenwett JL, Hallett JW, Johnston